Haleon Pakistan to manufacture Centrum multivitamins
Haleon Pakistan plans to start manufacturing multivitamin brand Centrum in the country for domestic sales and export, its CEO said, as it seeks to boost sales in the country amid lower inflation.
Related Articles
Advancements in colorectal cancer detection: The role of immuno‐positron emission tomography, immuno‐single‐photon emission computed tomography, and machine learning applications
Colorectal cancer (CRC) ranks as the world’s second most prevalent cancer and third in mortality. Detection and diagnosis are crucial in research and clinical settings.…
Why a virus-protection firm is paying $1 billion for MoneyLion
The merger pairs the fintech’s consumer lending platform with Gen Digital’s identity-protection services, such as Norton, LifeLock and ReputationDefender.
Thematic Issue on Dementia Policy and Practice
Dementia is a global public health priority with a wide range of implications for policy and practice. Nations, states, and local communities across the world…
In a threat to patient trust, Texas hospitals must ask ‘Are you a U.S. citizen?’
Akshara Ramasamy will soon begin medical school in Texas — but the state’s new requirement to ask hospital patients about immigration status worries her.
Jarvis, Google’s web-browsing AI, is now officially known as Project Mariner
Project Mariner is an experimental Chrome extension that can help you navigate websites.
Transforming healthcare in tier 2 & tier 3 cities with health IT – Express Healthcare
As health IT infrastructure advances and healthcare providers invest in tier 2 and 3 cities, these regions are set to become pivotal hubs for transformation,…
Decisions to decline breast screening and/or breast cancer treatment based on the potential harms of overdiagnosis and overtreatment: a qualitative study
Objectives To explore the experiences of women who have made the decision to decline breast screening and/or breast cancer treatment for overdiagnosis/overtreatment reasons after being…
Cervical cancer: Eight women develop cancer ‘after smear misread’
The review into cervical screening at the Southern Health Trust was triggered when the diagnoses of three women were investigated.
Tomorrow Capital-backed dialysis firm VitusCare on road to raise fresh funds
VitusCare, a Tomorrow Capital-backed kidney care startup, said Tuesday it intends to raise over $10 million (Rs 84.7 …